NATURE’S SUNSHINE PRODUCTS, INC. Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31)
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) of -$378.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-07.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised1 · last filed 2013-03-07
- NATURE’S SUNSHINE PRODUCTS, INC. tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2012 was -$378.00K.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-12-31 | -$378.00K 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |